| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |